COMMODORE CAPITAL LP's Net Worth
$0
Estimate Recalculated Nov 1, 2024 06:31AM EST
Who is COMMODORE CAPITAL LP?
COMMODORE CAPITAL LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Satsuma Pharmaceuticals, Inc., Vera Therapeutics, Inc., Vistagen Therapeutics, Inc., IMARA Inc., and Ambrx Biopharma Inc..
SEC CIK
COMMODORE CAPITAL LP's CIK is 0001831942
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Satsuma Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -87.57% | -3.25M |
$0.71 | -$2,294,500.00 | 461.29K |
Nov 14
| |||
Form 4
| +0.08% | 2.92K |
$5.42 | $15,837.24 | 3.71M |
Nov 24
| |||
Form 4
| +0.36% | 13.2K |
$5.48 | $72,328.71 | 3.71M |
Nov 19 - Nov 22
| |||
Form 4
| +0.48% | 17.56K |
$5.94 | $104,331.75 | 3.7M |
Nov 10 - Nov 11
| |||
Form 4
| +0.02% | 560 |
$5.99 | $3,354.40 | 3.68M |
Nov 8
| |||
Form 4
| +0.25% | 9.2K |
$5.94 | $54,642.00 | 3.68M |
Nov 4 - Nov 5
| |||
Form 4
| +0.24% | 8.88K |
$5.64 | $50,083.20 | 3.67M |
Nov 2
| |||
Form 4
| +1.24% | 44.65K |
$5.71 | $254,957.21 | 3.66M |
Oct 29
| |||
Form 4
| +1.54% | 54.66K |
$5.48 | $299,421.55 | 3.61M |
Oct 27 - Oct 28
| |||
Form 4
| +1.73% | 60.45K |
$5.45 | $329,442.19 | 3.56M |
Oct 21 - Oct 22
| |||
Form 4
| +3.80% | 128.24K |
$5.19 | $665,237.32 | 3.5M |
Oct 19 - Oct 20
| |||
Form 4
| +5.05% | 162.19K |
$4.84 | $784,844.78 | 3.37M |
Oct 15 - Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vera Therapeutics, Inc. (VERA) Snapshot price: $37.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.27% | -1.05M |
$18.00 | -$18,900,000.00 | 4.4M |
Jan 10
| |||
Form 4
| +8.96% | 448.22K |
$15.17 | $6,799,003.67 | 5.45M |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vistagen Therapeutics, Inc. (VTGN) Snapshot price: $3.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
| +97.06% | 775.76K |
$23.15 | $17,961,078.67 | 1.57M |
Aug 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMARA Inc. (ELVN) Snapshot price: $21.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +101.72% | 730.51K |
$22.07 |
—
| 1.45M |
Feb 23
| |||
Form 4
| +1.12% | 31.76K |
$5.15 | $163,498.15 | 2.87M |
Feb 21 - Feb 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ambrx Biopharma Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||